BioMarin Pharmaceutical ROI - Return on Investment 2010-2025 | BMRN

BioMarin Pharmaceutical return on investment for the quarter ending March 31, 2025 was 8.54.

  • BioMarin Pharmaceutical average return on investment for 2024 was 5.23, a 144.39% increase from 2023.
  • BioMarin Pharmaceutical average return on investment for 2023 was 2.14, a 47.59% increase from 2022.
  • BioMarin Pharmaceutical average return on investment for 2022 was 1.45, a 81.22% increase from 2021.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.

BioMarin Pharmaceutical ROI - Return on Investment 2010-2025 | BMRN

  • BioMarin Pharmaceutical average return on investment for 2024 was 5.23, a 144.39% increase from 2023.
  • BioMarin Pharmaceutical average return on investment for 2023 was 2.14, a 47.59% increase from 2022.
  • BioMarin Pharmaceutical average return on investment for 2022 was 1.45, a 81.22% increase from 2021.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.